Nnɛyi aduru a wɔde siw srade ano: Nea ɛsɛ sɛ wuhu fa PCSK9 Inhibitors ho

So ayɛ den ama wo pɛn sɛ wubedi wo srade a ɛwɔ wo mogya mu no so, ɛwom mpo sɛ woasɔ nnuru ahorow, aduan, ne apɔw-mu-teɛteɛ ahwɛ de? Ɛtɔ da bi a ɛba saa. Eyi yɛ asɛnnennen titiriw bere a wowɔ abusua abakɔsɛm a srade dɔɔso wom no. Ɛnnɛ, yɛreka nnuru foforo koraa a ebetumi aboa ho asɛm. Wɔfrɛ eyinom sɛ PCSK9 inhibitors.

Dɛn ne saa PCSK9 Inhibitors yi?

Sɛ yɛbɛka no tiawa a, eyinom yɛ nnuru a ano yɛ den a ɛma mogya mu srade so tew a wɔde ma sɛ nnuru a wɔde twitwiw nipadua no mu. Wɔde wɔn ani si LDL srade (Low-Density Lipoprotein Cholesterol) , "srade bɔne" a yɛn nyinaa nim sɛ enye mma yɛn nipadua no so titiriw. Nnuruyɛfo taa kyerɛw nnuru yi ma nnipa a wonnyaa nea wɔpɛ mfii nnuru afoforo a ɛma srade mu srade te sɛ statin mu bae, anaa nnipa a srade dɔɔso wɔ abusua mu.

Ɔkwan bɛn so na saa aduru yi yɛ adwuma wɔ nipadua no mu?

Sɛ yɛbɛte eyi ase a, momma yɛmfa nhwɛso ketewaa bi. Fa no sɛ srade bɔne (LDL) a ɛwɔ wo mogya mu no yɛ nwura bi. Sɛ yɛbɛyi saa nwura yi na yɛatew mogya no ho a, yɛn mmerɛbo no wɔ "nwura kotokuo" soronko bi wɔ ne ani. Eyi ne nea yɛfrɛ no LDL agyefo wɔ aduruyɛ mu . Nea saa ntini ahorow yi yɛ ne sɛ ɛkyere LDL srade a ɛwɔ mogya no mu no na ɛde kɔ mmerɛbo no mu ma ɛsɛe.

Afei, foforo bi nso reba ha. Ɛno yɛ protein bi a wɔfrɛ no PCSK9 . Yɛn mmerɛbo nso na ɛma eyi ba. Nanso PCSK9 protein yi adwuma ne sɛ ɛbɛsɛe LDL agyefo (yɛn nwura kotoku) a eyi srade fi mu no. Sɛ PCSK9 dodow kɔ soro wɔ nipadua no mu a, LDL agyefo pii sɛe. Afei srade a woyi fi mogya no mu no so tew, na srade dodow a ɛwɔ mogya no mu no kɔ soro.

Henanom na wɔkamfo aduru yi kyerɛ?

Eyi nyɛ aduru a wɔde ma obiara. Wo duruyɛfo begyina nneɛma pii so asi gyinae sɛ saa aduru yi fata wo anaa.

Mɛyɛ dɛn anya saa aduru yi?

Wɔde eyinom ma sɛ aduru a wɔde twitwiw nipadua mu, na ɛnyɛ aduru. Ɛdenam wo duruyɛfo nyansahyɛ so no, mpɛn pii no, wobɛma wo saa aduru yi wɔ ayaresabea anaa ayaresabea adapɛn anaa asram kakraa biara. Ahorow atitiriw abien a wɔde di dwuma mprempren wɔ Sri Lanka ne Alirocumab (Praluent®) ne Evolocumab (Repatha®) .

Sɛ wofi ayaresa yi ase wie a, wo duruyɛfo no bɛyɛ wo mogya mu nhwehwɛmu daa na wahwɛ sɛnea srade a ɛwɔ wo srade mu no te mu ahwɛ sɛnea etu mpɔn.

Dɛn ne mfaso ne nea efi mu ba?

Mfaso titiriw a ɛwɔ aduru yi so ne sɛ etu mpɔn kɛse wɔ LDL srade dodow a ɛso tew mu. Sɛnea nhwehwɛmu ahorow bi kyerɛ no, wobetumi atew LDL dodow so 50% kosi 70% . Eyi ma asiane a ɛwɔ hɔ sɛ obi benya komayare, akisikuru, ne komayare afoforo so tew kɛse.

Ɛwom sɛ nnipa dodow no ara nnya nsunsuanso bɔne a anibere wom de, nanso ebinom betumi anya nketenkete.

• Ɛhohoro, ɛyɛ kɔkɔɔ, anaa ɛyaw wɔ baabi a wɔde aduru no guu no
• Ɔbrɛ a wɔte nka (Ɔbrɛ) .
• Ntini mu yaw
• Nsɛnkyerɛnne a ɛte sɛ atiridii

Ɛntaa mma sɛ nnipa binom benya nkɛntɛnso bi wɔ wɔn mmerɛbo anaa wɔn asaabo dwumadi so. Eyi nti na ɛho hia yiye sɛ wobɛkɔ wo duruyɛfo nkyɛn daa akɔhwɛ wo no . Sɛ wuhu sɛnkyerɛnne biara a ɛyɛ soronko a, ka kyerɛ wo duruyɛfo ntɛm ara.

So aduru yi nkutoo a wɔde bedi dwuma no nnɔɔso?

Eyi yɛ asɛmmisa a ɛho hia paa. Mmuae no ne sɛ, "Dabi, ɛnnɔɔso." PCSK9 inhibitors nyɛ nkonyaayi. Wɔyɛ ayaresa nhyehyɛe nyinaa fã biako pɛ.

Bere a worenya saa vaccine yi no, akyinnye biara nni ho sɛ ɛsɛ sɛ wohwɛ nea edidi so yi so:

• Aduan a ahoɔden wom: Di ngo, asikre, ne nkyene kakraa bi, na di nnuaba, nhabannuru, ne nnuan a ahoɔdennuru pii wom pii.
• Apɔw-mu-teɛteɛ daa: Fa wo ho hyɛ apɔw-mu-teɛteɛ te sɛ nantew anaa mmirikatu mu anyɛ yiye koraa no simma 30 da biara, anyɛ yiye koraa no nnafua 5 dapɛn biara.
• Adwennwen ano aduru: Adwene no a wobɛma adwo denam nneɛma te sɛ yoga ne nsusuwii so.
• Da a ɛfata: Da yiye nnɔnhwerew 7-8 da biara.
• Sigaretnom a wogyae: Sigaretnom ne tawanom a wogyae koraa.

Wubenya nea eye sen biara afi PCSK9 inhibitor therapy mu bere a wode asetra mu nsakrae yi bom no. Mma nnyae nnuru no nom anaasɛ ɛnsesa dodow a wɔde ma no da a wunnya wo duruyɛfo afotu.